lotis-9 trial design: loncastuximab tesirine plus rituximab in elderly patients with dlbcl
Published 1 year ago • 167 plays • Length 1:16Download video MP4
Download video MP3
Similar videos
-
1:29
lotis-9: loncastuximab tesirine and rituximab in unfit/frail patients with dlbcl
-
4:45
lotis-5: loncastuximab tesirine rituximab for elderly patients with r/r dlbcl
-
1:09
loncastuximab tesirine: long-term survival data from lotis-2 & insights into the lotis-7 trial
-
2:40
lotis-2: r/r dlbcl patient characteristics impact dor to loncastuximab tesirine
-
1:32
management and outcomes of elderly patients with lbcl
-
23:06
setting up the backtable
-
6:35
high grade diffuse large b-cell lymphoma: carole's story
-
6:28
cytoquest™ cr ctc enrichment - rbc lysis
-
2:33
tailoring chemotherapy: r-chop dose attenuation in elderly dlbcl
-
2:12
hiex: tasso ondemand training video
-
2:04
elderly dlbcl updates
-
0:45
key trials in cll and designing a concept for treatment
-
6:41
loncastuximab tesirine: a novel antibody-drug conjugate for dlbcl
-
0:41
ligasure™ portfolio nano-coating in surgical procedures
-
0:45
are mutations in terc template sequence reflected in telomeric repeats?
-
1:01
pirtobrutinib, venetoclax, and rituximab in the treatment of r/r cll: insights from the bruin trial
-
2:17
luseed vascular
-
1:16
xtechsearch 5 finalist technology overview: oxos medical
-
3:03
the evolution of treatment patterns and prognostic biomarkers in latin american cll patients